Harnessing neuroplasticity for clinical applications

Neuroplasticity can be defined as the ability of the nervous system to respond to intrinsic or extrinsic stimuli by reorganizing its structure, function and connections. Major advances in the understanding of neuroplasticity have to date yielded few established interventions. To advance the translat...

Full description

Bibliographic Details
Main Authors: Cramer, Steven C., Sur, Mriganka, Dobkin, Bruce H., O’Brien, Charles, Sanger, Terence D., Trojanowski, John Q., Rumsey, Judith M., Hicks, Ramona, Cameron, Judy, Chen, Daofen, Chen, Wen G., Cohen, Leonardo G., deCharms, Christopher, Duffy, Charles J., Eden, Guinevere F., Fetz, Eberhard E., Filart, Rosemarie, Freund, Michelle, Grant, Steven J., Haber, Suzanne, Kalivas, Peter W., Kolb, Bryan, Kramer, Arthur F., Lynch, Minda, Mayberg, Helen S., McQuillen, Patrick S., Nitkin, Ralph, Pascual-Leone, Alvaro, Reuter-Lorenz, Patricia, Schiff, Nicholas, Sharma, Anu, Shekim, Lana, Stryker, Michael, Sullivan, Edith V., Vinogradov, Sophia
Other Authors: Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Format: Article
Language:en_US
Published: Oxford University Press 2019
Online Access:https://hdl.handle.net/1721.1/121189
_version_ 1811069876344717312
author Cramer, Steven C.
Sur, Mriganka
Dobkin, Bruce H.
O’Brien, Charles
Sanger, Terence D.
Trojanowski, John Q.
Rumsey, Judith M.
Hicks, Ramona
Cameron, Judy
Chen, Daofen
Chen, Wen G.
Cohen, Leonardo G.
deCharms, Christopher
Duffy, Charles J.
Eden, Guinevere F.
Fetz, Eberhard E.
Filart, Rosemarie
Freund, Michelle
Grant, Steven J.
Haber, Suzanne
Kalivas, Peter W.
Kolb, Bryan
Kramer, Arthur F.
Lynch, Minda
Mayberg, Helen S.
McQuillen, Patrick S.
Nitkin, Ralph
Pascual-Leone, Alvaro
Reuter-Lorenz, Patricia
Schiff, Nicholas
Sharma, Anu
Shekim, Lana
Stryker, Michael
Sullivan, Edith V.
Vinogradov, Sophia
author2 Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
author_facet Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Cramer, Steven C.
Sur, Mriganka
Dobkin, Bruce H.
O’Brien, Charles
Sanger, Terence D.
Trojanowski, John Q.
Rumsey, Judith M.
Hicks, Ramona
Cameron, Judy
Chen, Daofen
Chen, Wen G.
Cohen, Leonardo G.
deCharms, Christopher
Duffy, Charles J.
Eden, Guinevere F.
Fetz, Eberhard E.
Filart, Rosemarie
Freund, Michelle
Grant, Steven J.
Haber, Suzanne
Kalivas, Peter W.
Kolb, Bryan
Kramer, Arthur F.
Lynch, Minda
Mayberg, Helen S.
McQuillen, Patrick S.
Nitkin, Ralph
Pascual-Leone, Alvaro
Reuter-Lorenz, Patricia
Schiff, Nicholas
Sharma, Anu
Shekim, Lana
Stryker, Michael
Sullivan, Edith V.
Vinogradov, Sophia
author_sort Cramer, Steven C.
collection MIT
description Neuroplasticity can be defined as the ability of the nervous system to respond to intrinsic or extrinsic stimuli by reorganizing its structure, function and connections. Major advances in the understanding of neuroplasticity have to date yielded few established interventions. To advance the translation of neuroplasticity research towards clinical applications, the National Institutes of Health Blueprint for Neuroscience Research sponsored a workshop in 2009. Basic and clinical researchers in disciplines from central nervous system injury/stroke, mental/addictive disorders, paediatric/developmental disorders and neurodegeneration/ageing identified cardinal examples of neuroplasticity, underlying mechanisms, therapeutic implications and common denominators. Promising therapies that may enhance training-induced cognitive and motor learning, such as brain stimulation and neuropharmacological interventions, were identified, along with questions of how best to use this body of information to reduce human disability. Improved understanding of adaptive mechanisms at every level, from molecules to synapses, to networks, to behaviour, can be gained from iterative collaborations between basic and clinical researchers. Lessons can be gleaned from studying fields related to plasticity, such as development, critical periods, learning and response to disease. Improved means of assessing neuroplasticity in humans, including biomarkers for predicting and monitoring treatment response, are needed. Neuroplasticity occurs with many variations, in many forms, and in many contexts. However, common themes in plasticity that emerge across diverse central nervous system conditions include experience dependence, time sensitivity and the importance of motivation and attention. Integration of information across disciplines should enhance opportunities for the translation of neuroplasticity and circuit retraining research into effective clinical therapies. Keywords: neuroplasticity; retraining; therapeutics; clinical assessment
first_indexed 2024-09-23T08:18:22Z
format Article
id mit-1721.1/121189
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T08:18:22Z
publishDate 2019
publisher Oxford University Press
record_format dspace
spelling mit-1721.1/1211892022-09-23T12:10:52Z Harnessing neuroplasticity for clinical applications Cramer, Steven C. Sur, Mriganka Dobkin, Bruce H. O’Brien, Charles Sanger, Terence D. Trojanowski, John Q. Rumsey, Judith M. Hicks, Ramona Cameron, Judy Chen, Daofen Chen, Wen G. Cohen, Leonardo G. deCharms, Christopher Duffy, Charles J. Eden, Guinevere F. Fetz, Eberhard E. Filart, Rosemarie Freund, Michelle Grant, Steven J. Haber, Suzanne Kalivas, Peter W. Kolb, Bryan Kramer, Arthur F. Lynch, Minda Mayberg, Helen S. McQuillen, Patrick S. Nitkin, Ralph Pascual-Leone, Alvaro Reuter-Lorenz, Patricia Schiff, Nicholas Sharma, Anu Shekim, Lana Stryker, Michael Sullivan, Edith V. Vinogradov, Sophia Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences Sur, Mriganka Neuroplasticity can be defined as the ability of the nervous system to respond to intrinsic or extrinsic stimuli by reorganizing its structure, function and connections. Major advances in the understanding of neuroplasticity have to date yielded few established interventions. To advance the translation of neuroplasticity research towards clinical applications, the National Institutes of Health Blueprint for Neuroscience Research sponsored a workshop in 2009. Basic and clinical researchers in disciplines from central nervous system injury/stroke, mental/addictive disorders, paediatric/developmental disorders and neurodegeneration/ageing identified cardinal examples of neuroplasticity, underlying mechanisms, therapeutic implications and common denominators. Promising therapies that may enhance training-induced cognitive and motor learning, such as brain stimulation and neuropharmacological interventions, were identified, along with questions of how best to use this body of information to reduce human disability. Improved understanding of adaptive mechanisms at every level, from molecules to synapses, to networks, to behaviour, can be gained from iterative collaborations between basic and clinical researchers. Lessons can be gleaned from studying fields related to plasticity, such as development, critical periods, learning and response to disease. Improved means of assessing neuroplasticity in humans, including biomarkers for predicting and monitoring treatment response, are needed. Neuroplasticity occurs with many variations, in many forms, and in many contexts. However, common themes in plasticity that emerge across diverse central nervous system conditions include experience dependence, time sensitivity and the importance of motivation and attention. Integration of information across disciplines should enhance opportunities for the translation of neuroplasticity and circuit retraining research into effective clinical therapies. Keywords: neuroplasticity; retraining; therapeutics; clinical assessment 2019-05-31T20:37:51Z 2019-05-31T20:37:51Z 2011-06 2011-01 Article http://purl.org/eprint/type/JournalArticle 0006-8950 1460-2156 https://hdl.handle.net/1721.1/121189 Cramer, Steven C. et al. "Harnessing neuroplasticity for clinical applications." Brain 134, 6 (June 2011): 1591-1609 en_US http://dx.doi.org/10.1093/brain/awr039 Brain Creative Commons Attribution NonCommercial License 2.5 http://creativecommons.org/licenses/by-nc/2.5 application/pdf Oxford University Press Oxford
spellingShingle Cramer, Steven C.
Sur, Mriganka
Dobkin, Bruce H.
O’Brien, Charles
Sanger, Terence D.
Trojanowski, John Q.
Rumsey, Judith M.
Hicks, Ramona
Cameron, Judy
Chen, Daofen
Chen, Wen G.
Cohen, Leonardo G.
deCharms, Christopher
Duffy, Charles J.
Eden, Guinevere F.
Fetz, Eberhard E.
Filart, Rosemarie
Freund, Michelle
Grant, Steven J.
Haber, Suzanne
Kalivas, Peter W.
Kolb, Bryan
Kramer, Arthur F.
Lynch, Minda
Mayberg, Helen S.
McQuillen, Patrick S.
Nitkin, Ralph
Pascual-Leone, Alvaro
Reuter-Lorenz, Patricia
Schiff, Nicholas
Sharma, Anu
Shekim, Lana
Stryker, Michael
Sullivan, Edith V.
Vinogradov, Sophia
Harnessing neuroplasticity for clinical applications
title Harnessing neuroplasticity for clinical applications
title_full Harnessing neuroplasticity for clinical applications
title_fullStr Harnessing neuroplasticity for clinical applications
title_full_unstemmed Harnessing neuroplasticity for clinical applications
title_short Harnessing neuroplasticity for clinical applications
title_sort harnessing neuroplasticity for clinical applications
url https://hdl.handle.net/1721.1/121189
work_keys_str_mv AT cramerstevenc harnessingneuroplasticityforclinicalapplications
AT surmriganka harnessingneuroplasticityforclinicalapplications
AT dobkinbruceh harnessingneuroplasticityforclinicalapplications
AT obriencharles harnessingneuroplasticityforclinicalapplications
AT sangerterenced harnessingneuroplasticityforclinicalapplications
AT trojanowskijohnq harnessingneuroplasticityforclinicalapplications
AT rumseyjudithm harnessingneuroplasticityforclinicalapplications
AT hicksramona harnessingneuroplasticityforclinicalapplications
AT cameronjudy harnessingneuroplasticityforclinicalapplications
AT chendaofen harnessingneuroplasticityforclinicalapplications
AT chenweng harnessingneuroplasticityforclinicalapplications
AT cohenleonardog harnessingneuroplasticityforclinicalapplications
AT decharmschristopher harnessingneuroplasticityforclinicalapplications
AT duffycharlesj harnessingneuroplasticityforclinicalapplications
AT edenguineveref harnessingneuroplasticityforclinicalapplications
AT fetzeberharde harnessingneuroplasticityforclinicalapplications
AT filartrosemarie harnessingneuroplasticityforclinicalapplications
AT freundmichelle harnessingneuroplasticityforclinicalapplications
AT grantstevenj harnessingneuroplasticityforclinicalapplications
AT habersuzanne harnessingneuroplasticityforclinicalapplications
AT kalivaspeterw harnessingneuroplasticityforclinicalapplications
AT kolbbryan harnessingneuroplasticityforclinicalapplications
AT kramerarthurf harnessingneuroplasticityforclinicalapplications
AT lynchminda harnessingneuroplasticityforclinicalapplications
AT mayberghelens harnessingneuroplasticityforclinicalapplications
AT mcquillenpatricks harnessingneuroplasticityforclinicalapplications
AT nitkinralph harnessingneuroplasticityforclinicalapplications
AT pascualleonealvaro harnessingneuroplasticityforclinicalapplications
AT reuterlorenzpatricia harnessingneuroplasticityforclinicalapplications
AT schiffnicholas harnessingneuroplasticityforclinicalapplications
AT sharmaanu harnessingneuroplasticityforclinicalapplications
AT shekimlana harnessingneuroplasticityforclinicalapplications
AT strykermichael harnessingneuroplasticityforclinicalapplications
AT sullivanedithv harnessingneuroplasticityforclinicalapplications
AT vinogradovsophia harnessingneuroplasticityforclinicalapplications